Megadose Methylprednisolone (MDMP) for the Treatment of Steroid Refractory Patient with Diamond-Blackfan (D-B) Anemia
نویسندگان
چکیده
منابع مشابه
Oral megadose methylprednisolone for Diamond-Blackfan anemia.
I have read the report of Olivieri et al’ in the May 1, 1994 issue of BLOOD. Although the investigators stated that “in standard practice, treatment options are limited to two: steroid therapy or RBC transfusions,” they ignore our very good results obtained with megadose methylprednisolone (MDMP; initial dose 30 to 100 mgkg/d for 3 days followed progressive halving of the dose every 4 to 7 days...
متن کاملMegadose Methylprednisolone (MDMP) for Hemangiomatosis
Dr. Küpeli and his colleagues[1] should be congratulated for their success in treating hemangiomatosis, which could be life threatining depending on the localization of hemangiomas, with propranolol. I prefer the term infantile hemangiomatosis instead of segmental hemangiomatosis[ 2] for the authors’ patient. My primary reason in writing this letter is to clarify MDMP treatment, which caused se...
متن کاملMegadose Methylprednisolone (MDMP) for Hemangiomatosis
Reply In response to " Megadose Methylprednisolone (MDMP) for Hemangiomatosis " We are grateful to Dr. Özsoylu for his valuable comments on our case report concerning the treatment of hemangiomatosis with propranolol [1]. One of the issues raised by Dr. Özsoylu is regarding with the terminology used to describe hemangiomatous lesions. Although the term infantile hemangiomatosis could be used so...
متن کاملMegadose Methylprednisolone (MDMP) For Granulocytic Sarcoma (GS)
95 To the Editor, Baytan et al.’s case report entitled, Cerebellar granulocytic sarcoma: A case report (2012; 19: 177-180), [1] provides an opportunity for me to remind physicians that short-course megadose methylprednisolone (MDMP: 30 mg/kg for 3 d, then 20 mg/kg for 4 d each dose administered over the course of 10-15 min intravenously or orally; calculated dose of powder put into a spoon and ...
متن کاملMegadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report
UNLABELLED A female in the Netherlands with severe autoimmune hemolytic anemia (AIHA) was treated with conventional corticosteroid (2 mg/kg/d in divided doses) and blood transfusions for 18 months without improvement. The presented patient responded to megadose methylprednisolone (MDMP) 30 mg/kg/d for 3 d, followed by 20 mg/kg for 4 d, and subsequently 10, 5, 2, and 1 mg/kg/d each for 1 week. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Turkish Journal of Hematology
سال: 2012
ISSN: 1300-7777,1308-5263
DOI: 10.5505/tjh.2012.24865